Literature DB >> 20492449

Limiting angiotensin II signaling with a cell-penetrating peptide mimicking the second intracellular loop of the angiotensin II type-I receptor.

Jun Yu, Linda Taylor, Dale Mierke, Eric Berg, Michael Shia, Jordan Fishman, Christine Sallum, Peter Polgar.   

Abstract

A cell-penetrating peptide consisting of the second intracellular loop (IC2) of the angiotensin II (AngII) type-I receptor (AT1) linked to the HIV-transactivating regulatory protein (TAT) domain was used to identify the role of this motif In intracellular signal transduction. HEK-293 cells stably transfected with AT1R cDNA and primary cultures of human pulmonary artery smooth muscle cells expressing endogenous AT1 receptor were exposed to the cell-penetrating peptide construct, and the effect on angiotensin II signaling was determined. The AT1 IC2 peptide effectively inhibited AngII-stimulated phosphatidylinositol turnover and calcium influx. It also limited the activation of Akt/PKB as determined by an inhibition of phosphorylation of Akt at Ser473, and completely abolished the AngII-dependent activation of the transcriptional factor NFkappaB. In contrast, the AT1 IC2 peptide had no effect on AngII/AT1 receptor activation of ERK. These results illustrate the potential of using cell-penetrating peptides to both delineate receptor-mediated signal transduction and to selectively regulate G protein-coupled receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20492449      PMCID: PMC2994263          DOI: 10.1111/j.1747-0285.2010.00985.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  21 in total

Review 1.  Protein transduction: unrestricted delivery into all cells?

Authors:  S R Schwarze; K A Hruska; S F Dowdy
Journal:  Trends Cell Biol       Date:  2000-07       Impact factor: 20.808

2.  Transduction of a functional domain of the AT1 receptor in neurons by HIV-Tat PTD.

Authors:  Jorge Vázquez; Chengwen Sun; Jianqing Du; Lucía Fuentes; Colin Sumners; Mohan K Raizada
Journal:  Hypertension       Date:  2002-12-16       Impact factor: 10.190

3.  Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes.

Authors:  Michael Peitz; Kurt Pfannkuche; Klaus Rajewsky; Frank Edenhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  Effects of intracellular tyrosine residue mutation and carboxyl terminus truncation on signal transduction and internalization of the rat bradykinin B2 receptor.

Authors:  G N Prado; L Taylor; P Polgar
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

5.  Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils.

Authors:  Derek Strassheim; Karim Asehnoune; Jong-Sung Park; Jae-Yeol Kim; Qianbin He; Donald Richter; Katherine Kuhn; Sanchayita Mitra; Edward Abraham
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

6.  Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide.

Authors:  Kesheng Zhao; Guoxiong Luo; Guo-Min Zhao; Peter W Schiller; Hazel H Szeto
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

7.  Cardiac transcriptional response to acute and chronic angiotensin II treatments.

Authors:  Jennie E Larkin; Bryan C Frank; Renee M Gaspard; Irena Duka; Haralambos Gavras; John Quackenbush
Journal:  Physiol Genomics       Date:  2004-07-08       Impact factor: 3.107

8.  Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor.

Authors:  Koichi Seta; Junichi Sadoshima
Journal:  J Biol Chem       Date:  2003-01-09       Impact factor: 5.157

9.  Endocytosis and targeting of exogenous HIV-1 Tat protein.

Authors:  D A Mann; A D Frankel
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

Review 10.  Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics.

Authors:  Frederic Heitz; May Catherine Morris; Gilles Divita
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

View more
  7 in total

1.  Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration.

Authors:  Aurélie Borrull; Bertrand Allard; Anne Wijkhuisen; Amaury Herbet; Patricia Lamourette; Wided Birouk; Denis Leiber; Zahra Tanfin; Frédéric Ducancel; Didier Boquet; Jean-Yves Couraud; Philippe Robin
Journal:  MAbs       Date:  2016-07-08       Impact factor: 5.857

2.  Enhancing and limiting endothelin-1 signaling with a cell-penetrating peptide mimicking the third intracellular loop of the ETB receptor.

Authors:  Christine O Sallum; Jamie L Wilson; Chamila Rupasinghe; Eric Berg; Jun Yu; Daniel S Green; Linda Taylor; Dale Mierke; Peter Polgar
Journal:  Chem Biol Drug Des       Date:  2012-06-27       Impact factor: 2.817

3.  Targeting receptor tyrosine kinases and their downstream signaling with cell-penetrating peptides in human pulmonary artery smooth muscle and endothelial cells.

Authors:  Jun Yu; Chamila Rupasinghe; Jamie L Wilson; Linda Taylor; Nader Rahimi; Dale Mierke; Peter Polgar
Journal:  Chem Biol Drug Des       Date:  2014-11-05       Impact factor: 2.817

4.  Calcium mediates glomerular filtration through calcineurin and mTORC2/Akt signaling.

Authors:  John Vassiliadis; Christina Bracken; Douglas Matthews; Stephen O'Brien; Susan Schiavi; Stefan Wawersik
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

Review 5.  Knocking out angiotensin II in the heart.

Authors:  Daniela Zablocki; Junichi Sadoshima
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

6.  A cell permeable peptide targeting the intracellular loop 2 of endothelin B receptor reduces pulmonary hypertension in a hypoxic rat model.

Authors:  Daniel S Green; Chamila Rupasinghe; Rod Warburton; Jamie L Wilson; Christine O Sallum; Linda Taylor; Achani Yatawara; Dale Mierke; Peter Polgar; Nicholas Hill
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

7.  The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors.

Authors:  Flavia Anna Mercurio; Concetta Di Natale; Luciano Pirone; Roberta Iannitti; Daniela Marasco; Emilia Maria Pedone; Rosanna Palumbo; Marilisa Leone
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.